PureTech Health (PRTC LN)

Analysis

Health Care • United States

PureTech Health is a clinical-stage biotherapeutics company that discovers, develops, and commercializes medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases, and neurological and neuropsychological disorders. The company focuses on enhancing on-target efficacy, enabling oral administration, or improving tolerability to unlock new classes of medicine. PureTech Health was founded in 2005 and is headquartered in Boston, Massachusetts, United States.

Refresh

Company Presentation • 12 Jan 2022 20:30

JPMorgan 40th Annual Healthcare Conference

Company Presentation • 16 Dec 2024 22:00

Status Update

Company Presentation • 12 Aug 2024 14:00

Corporate Presentation

Company Presentation • 11 Apr 2024 23:30

Corporate Presentation

Company Presentation • 26 Apr 2022 08:03

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

JPMorgan 40th Annual Healthcare Conference

Status Update

Corporate Presentation

Corporate Presentation

H2 2021